Zepbound® and Mounjaro® cost and coverage guide

Zepbound® and Mounjaro® cost worries can hit before you even fill the pen. That fear is common. You are not alone in it.

Maybe your plan covered one brand and not the other. Maybe a letter mentioned prior authorization. It can feel confusing and unfair.

Here is the calm version. The two brands hold the same medicine, yet they can be covered in very different ways.

In animal studies, tirzepatide caused these tumors in rats. Whether it does this in people is not known.

Do not use either brand if you or a family member has had medullary thyroid cancer (MTC) or MEN 2.

Tell your doctor about any lump or swelling in your neck, trouble swallowing, or a hoarse voice.

Zepbound® and Mounjaro® cost: one medicine, two coverage stories

Zepbound® and Mounjaro® cost questions almost always come down to coverage, not the drug itself.

Both pens hold tirzepatide, the same medicine made by Eli Lilly. The molecule does not change between them.

What changes is the label. Each brand has a different FDA-approved job, and that shapes how plans treat it.

So the real driver is not a sticker price. It is how your plan sorts each brand into its own benefit bucket.

You might hear that one brand is cheaper than the other. That framing misses the real story. The price you face depends on your plan, not the pen.

Two people can pay very different amounts for the same brand. Their plans, states, and pharmacies are simply not the same.

The medicine is the same in both pens. The coverage is where the two brands part ways.

Same medicine, different FDA-approved jobs

Zepbound® and Mounjaro® are two brand names for tirzepatide. Eli Lilly makes both as a once-weekly shot.

Zepbound® is approved for chronic weight management in adults with obesity. It also covers adults who are overweight with a weight-related health problem.

Zepbound® is also approved for moderate-to-severe obstructive sleep apnea in adults with obesity. That is a second job on its label.

Mounjaro® is approved to improve blood sugar in type 2 diabetes. It is for adults and kids 10 and up.

For context, Zepbound® was studied in the SURMOUNT-1 trial for weight. That trial ran 72 weeks with 2,539 adults.

Mounjaro® was studied in the SURPASS-2 trial for blood sugar. That trial ran 40 weeks with 1,879 people.

The point is simple. One medicine earned two different approvals, and plans cover those two jobs in different ways.

This matters for your wallet in a direct way. A plan may treat a diabetes drug and a weight drug under separate rules.

How insurance coverage differs by indication

Coverage varies by plan and state, so no single rule fits everyone. Still, a clear pattern shows up again and again.

Type 2 diabetes drugs are often seen as medically necessary. Mounjaro® tends to be covered more often for that reason.

Weight-management drugs are treated differently by many plans. Zepbound® for weight is often not covered, or it needs extra steps first.

Zepbound® for sleep apnea is a newer approval. Coverage for that use is still uneven and depends on your plan.

So the same person could see one brand covered and the other denied. The diagnosis on the prescription drives that split.

Employer plans and marketplace plans can differ here too. One employer may cover weight care while another leaves it out.

Plans often cover the diabetes job more readily than the weight job, even for the same molecule.

What shapes your out-of-pocket amount

Several things decide what you pay for Zepbound® or Mounjaro® at the counter. None of them is a fixed number, and all of them can shift.

Your plan type, since commercial, Medicare, and Medicaid plans follow different rules.

The approved use on your prescription, because diabetes and weight are treated differently.

Whether prior authorization or step therapy applies to your brand.

Your eligibility for a Lilly savings program, which excludes government plans.

Your state and pharmacy, since coverage and access vary by location.

Because these pieces move, the amount you pay can change over time. Checking each one keeps you from guessing.

Zepbound® and Mounjaro® coverage, side by side

Here is the quick coverage picture, brand by brand, with no prices attached.

Brand	FDA-approved use	Typical coverage pattern	Common access hurdle	Lilly savings program
Zepbound®	Chronic weight management and moderate-to-severe OSA in adults with obesity	Often not covered for weight; varies by plan and state	Prior authorization or step therapy is common	May apply for eligible people with commercial insurance; government plans excluded
Mounjaro®	Glycemic control in type 2 diabetes (adults and kids 10 and up)	More often covered as medically necessary; varies by plan and state	Prior authorization possible, usually less often	May apply for eligible people with commercial insurance; government plans excluded

Zepbound® and Mounjaro® coverage at a glance. Coverage varies by plan and state; no prices are quoted.

Prior authorization and step therapy in plain words

Two words show up a lot with these brands. They are prior authorization and step therapy. Both are common hurdles.

Prior authorization means your plan wants proof first. Your doctor sends details before the plan agrees to pay.

Step therapy means you may need to try a lower-cost option first. Only if that fails will the plan move to the next choice.

Zepbound® for weight management runs into these steps more often. Mounjaro® for diabetes can face them too, though less often.

These hurdles are not a dead end. They are paperwork steps, and your provider can guide you through them.

Ask your clinic who handles the forms. A prepared office can make prior authorization far less stressful.

A denial after prior authorization is not final either. You can often appeal, and your doctor can add more detail.

Keep copies of every letter and form. A clear paper trail makes an appeal much easier to file.

Manufacturer savings programs from Lilly

Eli Lilly runs savings programs for both Zepbound® and Mounjaro®. These programs exist to help lower out-of-pocket cost.

There are rules, though. Savings programs may apply for eligible people with commercial insurance.

Government plans are excluded. That includes Medicare, Medicaid, VA, and TRICARE beneficiaries.

Eligibility and other restrictions apply, and terms can change. Always check the current program details before you count on it.

The programs do not replace coverage. They sit alongside your plan for people who qualify.

Your provider or pharmacist can help you see if you qualify. It is worth asking early, not after the fact.

Savings help looks different for each person. What one reader qualifies for, another may not, based on their insurance type.

When your plan says no: self-pay and telehealth routes

A denial is not the end of the road. When a plan does not cover a brand, other routes exist.

Some people choose a self-pay path. No insurance is required to explore that option.

Telehealth platforms offer another way to reach care and prescriptions. Many support self-pay and accessible pricing without a plan.

These routes vary widely in how they operate. The medicine is the same FDA-approved product wherever it is filled.

Because access differs, the fair thing to compare is service, not the drug. Look at prescriber access, follow-up, and refund terms.

This guide does not name providers. Our providers comparison does that work in one place.

Coverage help is part of good service too. Some platforms assist with prior authorization and appeals, which can save you time.

A denial is a detour, not a dead end. Self-pay and telehealth can open another door.

Coverage can change during the year

Coverage is not frozen. Plan formularies update, sometimes more than once a year.

A brand covered in January may shift by summer. A denied brand may open up later too.

That is why it helps to re-check before each refill. A quick call can save a surprise at the pharmacy.

Here is a simple way to check your own Zepbound® and Mounjaro® coverage:

1. Look up your plan formulary and search for Zepbound® and Mounjaro® by name.

2. Ask if the brand you need requires prior authorization or step therapy.

3. Ask your provider to confirm the diagnosis and approved use on the prescription.

4. Check whether a Lilly savings program fits your insurance type and eligibility.

5. If coverage is denied, ask about self-pay and telehealth options with accessible pricing.

Write down the answers as you go. Coverage can change, so your notes make the next call faster.

Open enrollment is a good moment to review your options. You can compare how each plan handles these brands before you choose.

7. Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT-1). NEJM 2022;387:205-216. NCT04184622.

8. Frias JP, et al. Tirzepatide versus semaglutide once weekly in type 2 diabetes (SURPASS-2). NEJM 2021. NCT03987919.

Frequently asked questions

Does insurance cover Zepbound® and Mounjaro®?

Coverage varies by plan and state, so there is no single answer. Many plans cover Mounjaro® for type 2 diabetes as medically necessary. Zepbound® for weight management is often not covered, or it needs prior authorization first. The best step is to check your own plan formulary and ask your provider to confirm the approved use.

Why is Mounjaro® often covered when Zepbound® is not?

The difference is the approved job, not the drug. Both brands are tirzepatide, but plans sort them into different benefit buckets. Type 2 diabetes care is often treated as medically necessary, so Mounjaro® tends to clear coverage more easily. Weight-management drugs like Zepbound® face more limits, more denials, and more paperwork. Coverage still varies by plan and state.

What are the Zepbound® and Mounjaro® savings programs?

Eli Lilly offers savings programs for both Zepbound® and Mounjaro®. They may apply for eligible people with commercial insurance. Government plans are excluded, including Medicare, Medicaid, VA, and TRICARE. Eligibility and other restrictions apply, and the terms can change over time. These programs do not replace coverage. Ask your pharmacist whether you qualify before you rely on one.

What is prior authorization?

Prior authorization is a check your plan runs before it agrees to pay. Your doctor sends details that show why you need the brand. This step is common for Zepbound® used for weight management. It can also apply to Mounjaro®, though often less often. Ask your clinic who handles the forms, since a prepared office can speed the whole process up.

What if my plan does not cover Zepbound® or Mounjaro®?

A denial is not the end. Self-pay routes exist, and no insurance is required to explore them. Telehealth platforms offer another way to reach care and prescriptions, often with accessible pricing. The medicine is the same FDA-approved product wherever it is filled, so the fair thing to compare is service. Look at prescriber access, follow-up support, and refund terms before you choose.

Do Medicare or Medicaid help with these brands or the savings programs?

Government plans work differently from commercial insurance here. The Lilly savings programs exclude Medicare, Medicaid, VA, and TRICARE beneficiaries. Whether the drug itself is covered depends on the specific plan, the approved use, and your state. Coverage for weight-management use is often more limited under these plans. Ask your plan directly, since rules change and vary widely by program.

Can coverage for Zepbound® and Mounjaro® change during the year?

Yes. Plan formularies update, sometimes more than once a year. A brand covered in the spring may shift by the fall, and a denied brand may open up later. That is why it helps to re-check before each refill. A quick call to your plan or pharmacy can prevent a surprise. Keep notes so your next check goes faster.

Is one brand cheaper than the other?

There is no fixed price to compare, so cheaper is the wrong question. What you pay depends on your plan, your state, and your pharmacy. Because the two brands sit in different benefit buckets, coverage often matters more than any list amount. Focus on whether your plan covers the brand your doctor prescribed. Then look at savings or self-pay options if it does not.

Important: This page is for education only and is not medical advice. Any medicines named here are available by prescription. Always talk to a licensed clinician about medicines, symptoms, or anything you are considering.